---
title: "Oseltamivir Aziridines as Influenza Neuraminidase Inhibitors and Imaging Agents"
id: "pnas-13-oseltamivir-aziridines-are-potent-influenza-neuraminidase-inhibitors-and-imaging-agents"
canonical_url: "https://medichelpline.com/clinical-feed/pnas-13-oseltamivir-aziridines-are-potent-influenza-neuraminidase-inhibitors-and-imaging-agents"
content_type: "clinical_feed_article"
specialty: "Research Highlights"
source_name: "PNAS"
source_url: "https://www.pnas.org/doi/abs/10.1073/pnas.2504045123?af=R"
published_at: "2026-03-23T07:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Oseltamivir Aziridines as Influenza Neuraminidase Inhibitors and Imaging Agents
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pnas-13-oseltamivir-aziridines-are-potent-influenza-neuraminidase-inhibitors-and-imaging-agents
- **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md)
- **Primary Source:** PNAS
- **Source URL:** [Original Journal Publication](https://www.pnas.org/doi/abs/10.1073/pnas.2504045123?af=R)
- **Published At:** 2026-03-23T07:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
Proceedings of the National Academy of Sciences, Volume 123, Issue 13, March 2026. SignificanceInfluenza remains a major global health threat. We introduce oseltamivir-based aziridines that unite transition-state mimicry for tight binding with aziridine-enabled covalent capture of the catalytic tyrosine. This dual function yields potent,...
## Clinical Analysis & Structured Key Points
PNAS published a clinical update in Research Highlights on 23 Mar 2026. The item focuses on Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents. Review the original article for the full source wording and details.
## Related Clinical Research

- [Pharmacokinetic variability of baloxavir marboxil among 14 rare avian species](https://medichelpline.com/clinical-feed/plos-one-16-pharmacokinetic-diversity-of-baloxavir-marboxil-across-rare-avian-species.md)
- [Baloxavir-Based Combination Therapy Protects Mice from Influenza A(H5N1) Clade 2.3.4.4b](https://medichelpline.com/clinical-feed/pubmed-42811476.md) (DOI: 10.3201/eid3210.260186)
- [Baloxavir-Based Combinations Improve Survival and Virologic Control in H5N1-Infected Mice](https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-1-comparison-of-baloxavir-based-combinations-and-monotherapies-for-treating.md)
- [Effectiveness of Oseltamivir in Hospitalized Children With Laboratory-Confirmed Influenza (2014–20](https://medichelpline.com/clinical-feed/pubmed-42573991.md) (DOI: 10.1001/jamapediatrics.2026.3376)
- [mNGS-negative Strongyloides Hyperinfection Syndrome Presenting as Small Bowel Obstruction in a Glu](https://medichelpline.com/clinical-feed/frontiers-in-immunology-13-case-report-mngs-negative-strongyloides-hyperinfection-syndrome-with-small.md)

## Navigation
- [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.